Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas J Kojetin

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Elife|November 18, 2024
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγJinsai Shang, Douglas J Kojetin
Structure (London, England : 1993)|December 8, 2023
Go big and go home: A bulky extension makes promiscuous ligands settle downXiaoyu Yu, Douglas J Kojetin
Biorxiv : the Preprint Server for Biology|May 27, 2024
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγJinsai Shang, Douglas J Kojetin
Structure (London, England : 1993)|March 13, 2021
Structural mechanism underlying ligand binding and activation of PPARγJinsai Shang, Douglas J Kojetin
Molecular Pharmacology|August 8, 2012
Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discoveryDouglas J Kojetin, Thomas P Burris
Current Pharmaceutical Design|March 8, 2011
A role for rev-erbα ligands in regulation of adipogenesisDouglas J Kojetin, Thomas P Burris
Nature Reviews. Drug Discovery|March 1, 2014
REV-ERB and ROR nuclear receptors as drug targetsDouglas J Kojetin, Thomas P Burris
Elife|April 27, 2023
Molecular basis of ligand-dependent Nurr1-RXRα activationXiaoyu Yu, Jinsai Shang, Douglas J Kojetin
Elife|April 14, 2025
Correction: Molecular basis of ligand-dependent Nurr1-RXRα activationXiaoyu Yu, Jinsai Shang, Douglas J Kojetin
FEBS Letters|November 19, 2003
Sub-classification of response regulators using the surface characteristics of their receiver domainsDouglas J Kojetin, Richele J Thompson, John Cavanagh
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Elife|November 18, 2024
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγJinsai Shang, Douglas J Kojetin
Structure (London, England : 1993)|December 8, 2023
Go big and go home: A bulky extension makes promiscuous ligands settle downXiaoyu Yu, Douglas J Kojetin
Biorxiv : the Preprint Server for Biology|May 27, 2024
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγJinsai Shang, Douglas J Kojetin
Structure (London, England : 1993)|March 13, 2021
Structural mechanism underlying ligand binding and activation of PPARγJinsai Shang, Douglas J Kojetin
Molecular Pharmacology|August 8, 2012
Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discoveryDouglas J Kojetin, Thomas P Burris
Current Pharmaceutical Design|March 8, 2011
A role for rev-erbα ligands in regulation of adipogenesisDouglas J Kojetin, Thomas P Burris
Nature Reviews. Drug Discovery|March 1, 2014
REV-ERB and ROR nuclear receptors as drug targetsDouglas J Kojetin, Thomas P Burris
Elife|April 27, 2023
Molecular basis of ligand-dependent Nurr1-RXRα activationXiaoyu Yu, Jinsai Shang, Douglas J Kojetin
Elife|April 14, 2025
Correction: Molecular basis of ligand-dependent Nurr1-RXRα activationXiaoyu Yu, Jinsai Shang, Douglas J Kojetin
FEBS Letters|November 19, 2003
Sub-classification of response regulators using the surface characteristics of their receiver domainsDouglas J Kojetin, Richele J Thompson, John Cavanagh
Pageof 8